Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells

One of the promising strategies to overcome tumor multidrug resistance (MDR) is to deliver anticancer drug along with P-glycoprotein (P-gp) inhibitor simultaneously. To enhance the cancer cellular internalization and implement the controlled drug release, herein an iRGD peptide-modified lipid-polyme...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jinming, Wang, Lu, Fai Chan, Hon, Xie, Wei, Chen, Sheng, He, Chengwei, Wang, Yitao, Chen, Meiwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415764/
https://www.ncbi.nlm.nih.gov/pubmed/28470171
http://dx.doi.org/10.1038/srep46057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415764/
https://www.ncbi.nlm.nih.gov/pubmed/28470171
http://dx.doi.org/10.1038/srep46057

Ejemplares similares